William Stohl, MD, PhD

Dr. Stohl’s research focus is on systemic lupus erythematosus (pathogenesis, natural course of disease, treatment, animal models, immunologic disturbances, novel therapeutics); rheumatoid arthritis (pathogenesis, natural course of disease, treatment, animal models, immunologic disturbances, novel therapeutics); Sjogren’s syndrome (biomarkers, novel therapeutics); and B cells (basic biology, role in autoimmune diseases, development of targeted therapies).

Dr. Stohl received his M.D. (1977) and his Ph.D. (1979) from the University Pennsylvania.

• University of Pennsylvania School of Medicine: Upjohn Award, 1979
• Arthritis Foundation Southern California Chapter: James R. Klinenberg, M.D. Award, 2003

• The vital role of BAFF in the development of SLE
  NIH · R01AR050193 · May 16, 2006 – Aug 31, 2012 · Role: Principal Investigator
• T CELL CYTOLYTIC ACTIVITY IN SLE
  NIH · R01AR041006 · Aug 12, 1993 – Jun 30, 2002 · Role: Principal Investigator
• POLYMORPHISM WITHIN T4/LEU3 AND SLE
  NIH · R23AR036527 · Jan 1, 1986 – Jun 30, 1989 · Role: Principal Investigator

• Update: Progress in Lupus Tx Slow But Sure (07/24/2014)
• One Step Closer to Unlocking Lupus Mystery (05/30/2000)
• The Long, Winding Road to a Lupus Drug
• Welcome to the First FDA-Approved Drug for Lupus in 50 Years!
• Results of Phase 1 Clinical Trial Demonstrate That LymphoStat-B(TM) Is Safe and Biologically Active in Patients with Systemic Lupus Erythematosus

• Peters, Anne
• Wise, Leanna
• Lenz, Heinz-Josef
• Hamm-Alvarez, Sarah
• Arkfeld, Daniel
• Delgado, Martha